Potential Thrombogenic Complications With the Use of Recombinant Activated Factor VII in Combat Trauma

Clinical and Applied Thrombosis/Hemostasis - United States
doi 10.1177/1076029606298733
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Intraoperative Use of Recombinant Activated Factor VII During Complex Aortic Surgery

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2012English

Recombinant Activated Factor VII and Aortic Surgery

European Journal of Vascular and Endovascular Surgery
SurgeryCardiovascular MedicineCardiology
2013English

Preemptive Use of Recombinant Activated Factor VII: Many Questions but Few Answers

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2006English

The Use of Recombinant Activated Factor VII for Refractory Bleeding Post Complex Cardiothoracic Surgery

Anaesthesia and Intensive Care
Critical CareAnesthesiologyPain MedicineIntensive Care Medicine
2006English

Use of Recombinant Factor VII in Cardiac Surgery

Recent Patents on Cardiovascular Drug Discovery
2012English

Use of Recombinant Factor VIIa for Control of Combat-Related Hemorrhage: Findings From the U.S. Navy-Marine Corps Combat Trauma Registry

2007English

Successful Use of Recombinant Activated Factor VII for Postoperative Associated Haemorrhage: A Case Report

Cases Journal
2008English

Successful Management of Severe Bleeding After Redo Cardiac Transplantation With Recombinant Activated Factor VII

Journal of Clinical Case Reports
2012English

Recombinant Activated Factor VII (rFVIIa) Treatment of Refractory Bleeding in Cardiac Surgical Patients

Journal of Anesthesia & Clinical Research
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy